Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -13.48 | 55.26 |
| PEG Ratio (TTM) | -0.42 | 1.99 |
| P/S Ratio (TTM) | 1.93 | 1.47 |
| P/B Ratio (TTM) | 1.51 | 4.22 |
| P/FCF Ratio (TTM) | 36.65 | 16.07 |
| Price to 5YR AVG Earnings Ratio | N/A | -74.20 |
| Price to 5YR AVG FCF Ratio | N/A | 18.03 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.85% | 1.80% |
| ROE (TTM) | -10.97% | 20.08% |
| Net Profit Margin (TTM) | -14.15% | -6.40% |
| ROIC 5YR AVG | N/A | 18.76% |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -52.90% | -220.95% | N/A |
| Revenue | 2.48% | 31.38% | N/A |
| Net Income | -55.05% | -428.12% | N/A |
| Cash Flow | 228.79% | -29.01% | N/A |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.81 | 1.29 |
| Quick Ratio (TTM) | 2.81 | 1.27 |
| D/E Ratio (TTM) | 0.06 | 1.09 |
| Interest Coverage (TTM) | -3.25 | -0.70 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 3.09 | 2.01 |
| LTL to 5YR AVG FCF | N/A | 5.04 |
| Shares Outstanding Growth 5YR AVG | N/A | 16.53% |